Abstract Antipyrine and benzocaine are formulated together for the treatment of ear inflammation and to relieve pain. Four spectrophotometric methods were developed for the simultaneous determination of antipyrine (AN) and benzocaine (BE) in their combined dosage form. Method A depends on applying dual wavelength method where antipyrine was determined by measuring the absorbance at 254.1 and 309.1 nm (corresponding to zero difference of benzocaine), while the absorbance difference at 230.1 and 263.5 nm (corresponding to zero difference of antipyrine) was selected for benzocaine determination in the laboratory prepared spectrum. Method B depends on measuring the peak amplitude of first derivative at 305 nm for calculating benzocaine concentration then the total concentration of both drugs was determined using isoabsorptive point at 257.4 nm (antipyrine concentration was then calculated by subtraction). Method C is based on measuring the peak difference of the ratio spectra at Dp (239.1-285 nm) and Dp (301.4-250 nm) for the determination of antipyrine and benzocaine, respectively. Method D depends on measuring peak to peak amplitude of the first derivative of ratio spectra at (234.5 + 244.2 nm) and peak amplitude at 295.5 nm for the determination of antipyrine and benzocaine, respectively. The proposed methods were validated and applied for the analysis of antipyrine and benzocaine in their laboratory prepared mixtures and pharmaceutical formulation. Statistical comparison between the results of the proposed methods and those of the reported methods showed no significant difference.
Introduction
Antipyrine (phenazone) (AN, Fig. 1 ) is 1, 5-Dimethyl-2-phe nyl-4-pyrazolin-3-one, it is a NSAID that can relieve mild to moderate pain. 1 It is an official drug in USP 2 and BP 3 pharmacopeia. Several analytical methods were reported for the determination of AN either alone or coformulated with other drugs including spectrophotometric, 4 ,5 chemometric, 6, 7 HPLC, 8, 9 TLC, 10,11 GC, 12, 13 , capillary zone electrophoresis 14 and non aqueous titration 15 methods. Benzocaine (BE, Fig. 1 ) is a benzoic acid, 4-amino, ethyl ester (ethyl 4-aminobenzoate) acid ester. It is used as a local anesthetics for superficial anesthesia, for the local and temporal relief of pain related, to buccal infections. 1 BE is official in USP 2 and BP 3 pharmacopeia. BE was determined by several methods including; spectrophotometry [16] [17] [18] [19] [20] [21] , and HPLC. [22] [23] [24] [25] [26] HPLC method was also reported as a stability indicating method for BE. 27 Antipyrine (AN) and benzocaine (BE) are co-formulated in Egyptian market as ear drops for relief of pain and reduction of inflammation in the ear as in otitis externa and acute otitis media 15 . Usually combined dosage forms require more sophisticated analytical methods especially when their components interfere with each other during their analysis and control procedures to resolve the interference. 28 Only two HPLC methods were elaborated for the determination of benzocaine and antipyrine in the presence of BE degradation product. 29, 30 One TLC method was reported for the determination of benzocaine and antipyrine in the presence of BE degradation product. 30 From literature in hand, no spectrophotometric methods were used for the simultaneous determination of AN and BE, therefore the aim of this work was to develop and validate simple, precise, rapid and accurate spectrophotometric methods for the simultaneous determination of AN and BE in pure form or in pharmaceutical formulation.
Experimental

Instruments
SHIMADZU dual beam UV-visible spectrophotometer (Kyoto/Japan), model UV-1650 PC with a fixed slit width (1 nm). The bundle software is UV-Probe version 2.21 (Shimadzu). The instrument is equipped with HP1020 laser jet printer.
Chemicals and solvents
All chemicals used were of analytical grade: Double distilled water (SEDICO Pharmaceutical Co., Cairo, Egypt). Ethanol (Lab. Scan, Ireland).
Samples
Pure samples
Antipyrine (phenazone) and Benzocaine were kindly supplied by Amriya for pharmaceutical industries, Alexandria, Egypt. Purity of AN and BE was found to be 100.22 ± 1.375 and 99.47 ± 1.071 according to its reported method. 30 
Pharmaceutical formulation
OtoseptÒ ear drops are labeled to contain 300 mg of antipyrine and 100 mg of benzocaine in 10 mL of glycerin, It is manufactured by Amriya for pharmaceutical industries, (Alexandria, Egypt). Batch No. 857103 1 was purchased from Egyptian markets. The solution was prepared by dissolving 100 mg of AN in 100 mL double distilled water. Benzocaine (0.4 mg mL À1 ) The solution was prepared by dissolving 40 mg of BE in the least amount of ethanol then complete to 100 mL using double distilled water.
2.4.2.
Working standard solutions of AN (100 lg mL À1 ) and BE (40 lg mL À1 ) AN and BE working solutions were prepared by diluting 10 mL from their respective stock standard solutions 1 mg mL À1 and 0.4 mg mL À1 (for AN and BE, respectively) into two separate 100-mL volumetric flasks and the volume was completed with double distilled water.
Laboratory prepared mixtures
Different aliquots of AN and BE were separately transferred from their working standard solutions (100 lg mL À1 and 40 lg mL À1 , respectively) into a set of 10-mL volumetric flasks then the volume was completed to the mark with double distilled water to produce laboratory prepared mixtures containing different ratios of the cited drugs.
Procedure
ICH guidelines
31 for method validation were followed.
Spectral characteristics
Zero order absorption spectra of 30 lg mL À1 AN and 10 lg mL À1 BE in double distilled water were recorded over a wavelength range of 200-400 nm.
Linearity
Aliquots of AN and BE were separately transferred from their working standard solutions (100 lg mL À1 and 40 lg mL À1 , respectively) into two separate sets of 10-mL volumetric flasks. The volume was then made up to the mark with double distilled water to give samples having concentrations in the range of 5-50 lg mL À1 for AN and 1-20 lg mL À1 for BE. The zero First derivative of the stored zero order absorption spectra of BE was obtained using Dk = 8 and scaling factor = 10 and the peak amplitude at 305 nm (zero contribution of AN) was recorded and plotted against the corresponding BE concentrations then the regression equation was computed. The absorbance of the stored zero order absorption spectra of AN at 257.4 nm was recorded and plotted against the corresponding AN concentrations then the regression equation was computed.
For ratio difference method (method C)
The stored spectra of AN were divided by standard spectrum of BE (4 lg mL À1 ) as a divisor, then the values of peak difference of the obtained the ratio spectra at Dp (239.1-285 nm) were plotted against corresponding concentration of AN. Similarly, the stored spectra of BE were divided by standard spectrum of AN (5 lg mL
À1
) as a divisor and the values of peak difference of the obtained ratio spectra at Dp (301.4-250 nm) were calculated and plotted against corresponding concentrations of BE. The corresponding regression equations were also computed.
For derivative ratio spectra spectrophotometric method (method D)
The first derivative of the previously obtained ratio spectra of AN and BE (1DD) were manipulated using Dk = 4 and scaling factor = 10. The values of peak to peak of the obtained first derivative ratio spectra at (234.5 + 244.2 nm) and the peak amplitude at 295.5 nm were plotted against the corresponding concentrations of AN and BE, respectively. The regression equations and correlation coefficients were also computed.
Accuracy
The suggested methods have been applied for measuring different concentrations of AN and BE within their linearity ranges and the concentrations were calculated each from their corresponding regression equation. The percentage recoveries and SD for each drug were calculated. The validity of the proposed methods was further assessed by applying the standard addition technique.
Precision
Repeatability: Three concentrations of AN (5, 30 and 50 lg mL
À1
) and BE (4, 8 and 12 lg mL À1 ) were analyzed three times in triplicate on the same day, using the previously mentioned procedure under linearity. SD values were then calculated for each drug.
Intermediate precision: The above mentioned concentrations of AN and BE were analyzed on three successive days using the procedure stated under linearity. SD values for each drug were then calculated.
Specificity
The zero order absorption spectra of laboratory prepared mixtures were recorded, then the procedures were applied as described under linearity for each proposed method. The concentrations of AN and BE were calculated by substituting in the corresponding regression equations.
Application of the proposed methods for the determination of AN and BE in OtoseptÒ ear drops
A volume of ear drops equivalent to 30 mg AN and 10 mg BE was transferred into volumetric flask 100 mL then the volume was completed to the mark with double distilled water. An appropriate dilution was made using double distilled water to obtain solutions of final concentrations of AN and BE within their linearity. Then the procedure was completed as described under linearity. The concentrations of the cited drugs were obtained from the computed corresponding regression equations.
Results and discussion
By reviewing the literature it was revealed that, only two articles have been published as stability indicating methods for determination of benzocaine and antipyrine in the presence of degradation product of BE 29, 30 . No spectrophotometric methods were reported for the simultaneous analysis of AN and BE, this attract our attention to develop simple, rapid, precise and validated spectrophotometric methods for the simultaneous determination of AN and BE in pure form or in pharmaceutical formulation. Spectrophotometric methods do not require sample preparation, expensive instruments in addition to being less time consuming and economical in comparison to the HPLC method.
Dual wavelength spectrophotometric method offers an efficient method for analyzing a component in the presence of an interfering component. For elimination of interferences, dual analytical wavelengths were selected in a way to make the absorbance difference zero for one drug in order to analyze the other drug. 32 . Fig. 2 shows sever overlap between AN and BE in the wavelength range of 200-330 nm, so direct determination of AN and BE cannot be applied. Therefore, dual wave length was first tried for determination of the cited drugs. For the determination of AN, two wavelengths (254.1 and 309.1 nm) were selected where the absorbance difference between these wavelengths was directly proportional to the concentrations of AN in the concentration range of 5-50 lg mL
À1
, while the absorbance difference of BE at these wavelengths was zero. The absorbance difference at 230.1 and 263.5 nm was selected for determination of BE in the concentration range of 1-20 lg mL
, whereas, the absorbance difference of AN at these wavelengths was zero.
Derivative spectrophotometry is a well-established technique capable of enhancing the resolution of overlapped spectra. It can be applied for the determination of a substance in the presence of the other, by selecting wavelength where the contribution of one compound is zero while the other to be determined has a reasonable value. 33 . It was found that, the first derivative spectrophotometry (1D) failed to determine AN but BE can be selectively determined by measuring the peak amplitude of the first derivative spectra at 305 nm (Fig. 3) . Therefore, derivative spectrophotometry was coupled with isoabsorpative point spectrophotometric method to determine the total concentrations of AN and BE at 257.4 nm then AN concentration can be calculated by subtraction (Fig. 4) .
Recently, ratio difference spectrophotometric method was introduced as a novel method for the simultaneous determination of mixtures with overlapped spectra, in which the amplitude difference between two points on the ratio spectra of a mixture is directly proportional to the concentration of the component of interest; independence of the interfering component is the basic principle of the ratio difference method. 34 To apply this method for the simultaneous determination of AN and BE, different concentrations of AN and BE were tried as a divisor (1, 2 and 4 lg mL À1 , BE) and (5, 10 and 20 lg mL À1 , AN) for the determination of AN and BE, respectively. The selected divisor should compromise between low noise and maximum sensitivity. The best results were obtained upon using 4 lg mL À1 of BE and 5 lg mL À1 of AN as a divisor for the determination of AN and BE, respectively.
For the determination of AN concentration by the ratio difference method, after using BE as a divisor the only requirement was the contribution of the AN and BE at the two selected wavelengths (239.1 and 285 nm) where the ratio spectra of the BE showed the same amplitudes (constant) whereas AN ratio spectra showed significant difference in amplitude values at these two selected wavelengths with concentration, (Fig. 5) . Similarly, another two wavelengths (250 and 301.4 nm) were selected for the determination of the BE after using AN as a divisor, (Fig. 6 ). The selected wavelengths were found to be the best regarding sensitivity and linearity. Derivative ratio spectra spectrophotometric method was one of the popular methods used to solve the overlapped spectra. 35 It was tested for analysis of AN and BE in binary mixtures. This method was based on obtaining the ratio spectra of studied drug by dividing its absorption spectra by a standard spectrum of the interfering compound then the first derivative of the ratio spectra was computed. The main parameters that affect the sensitivity of derivative ratio spectra method are concentration of divisor and the wavelength increment over which the derivative is determined. The best results were obtained when using the spectrum of 4 lg mL À1 BE and 5 lg mL À1 AN as a divisor for the determination of AN and BE, respectively. Satisfying results regarding signal to noise ratio were obtained upon using Dk = 4 and scaling factor = 10 ( Figs. 7 and 8) . Upon using the previous conditions, the peak to peak of the first derivative of the ratio spectra at (234.5 + 244.2 nm) and the peak amplitude at 295.5 nm were used for the analysis of AN and BE, respectively.
Method validation
Linearity
For dual wavelength method Under the previous experimental conditions it was found that, linear relationship was obtained between the absorbance difference at the selected wavelengths (DA 254.1-309.1 and DA 230.1-263.5) and the corresponding concentrations of AN and BE. The regression equations were computed and the results are listed in Table 1 . For first derivative coupled with isoabsorpative method The linear correlation was obtained between the peak amplitude of the first derivative spectra at 305 nm and the corresponding concentrations of BE. The regression equation was computed. The linear correlation was obtained between the absorbance of AN at 257.4 nm and the corresponding concentrations of AN. This linearity was used to calculate the total concentration of AN and BE by substituting the absorbance of binary mixture or pharmaceutical formulation in equation to get the total concentration followed by subtraction the concentration of BE to found AN concentration. The regression equation was computed and the results are listed in Table 1 . For ratio difference method A linear relationship was obtained between the amplitude ratio difference (DP239.1-285) and (DP301.4-250) versus the corresponding concentration in the ranges of 5-50 lg mL À1 and 1-20 lg mL À1 for AN and BE, respectively. The parameters of the corresponding regression equations are shown in Table 1 . For derivative ratio spectra spectrophotometric method A linear relationship was obtained between the peak to peak amplitude of the first derivative ratio spectra at (234.5 + 244.2 nm) and the peak amplitude at 295.5 nm versus the corresponding concentration in the ranges of 5-50 lg mL À1 and 1-20 lg mL À1 for AN and BE, respectively. The data of the corresponding regression equations are shown in Table 1 .
Accuracy
The suggested methods were applied for measuring different concentrations of AN and BE within their linearity range and the concentrations were calculated each from their corresponding regression equations. The accuracy of the proposed methods was further assessed by applying the standard addition technique. Good results were obtained (Tables 1-3 ). Statistical comparison between the results obtained by the proposed spectrophotometric methods and the reported method 30 for the determination of pure antipyrine and benzocaine in pure powder form was also done. The values of calculated t and F are less than the tabulated ones, which reveals that there is no significant difference between the suggested methods with respect to accuracy and precision, (Table 4) .
Precision
Precision was evaluated by calculating intra-and interday precision after repeating the assay of the three different concentrations three times in the same day and assaying the sample in triplicate on three successive days using the proposed methods. The calculated S.D. was listed in Table 1 indicating satisfying precision of the proposed methods.
Specificity
Good recoveries were obtained upon applying the proposed methods for the determination of studied drugs in laboratory prepared mixtures containing different concentrations of AN and BE indicating good specificity (Table 5 ). Method A is dual wavelength, method B is first derivative coupled with isoabsorpative point, method C is ratio difference, method D is ratio derivative spectra spectrophotometric method.
*
Correlation coefficient.
**
The intraday precision (n = 9), average of three different concentrations repeated three times within day. The interday precision (n = 9), average of three different concentrations repeated three times in three successive days.
Analysis of OtoseptÒ ear drops by the proposed methods
The proposed methods were also used for the determination of An and BE in its pharmaceutical formulation. Satisfying results were obtained and listed in Tables 2 and 3 .
Conclusion
The proposed dual wavelength method was found to be simpler for quantitative determination of benzocaine and antipyrine HCl in laboratory prepared mixture in addition to pharmaceutical formulation. The main disadvantage of this method is the restriction in the choice of the selected wavelengths which are restricted to those wavelengths with constant absorbance of the interfering substance. This lead to the necessity of critical measurement of the absorbance of the component of interest, as any minor change in the selected wavelength will affect the results and subsequently shows poor reproducibility. Another disadvantage is the poor values obtained from absorbance differences of the two components which lead to poor sensitivity (as in benzocaine 4-20 lg mL
À1
). The proposed first derivative method (coupled with isoabsorpative point), ratio difference and derivative ratio spectra method, provide simple and rapid determination of cited drugs without prior separation with minimum calculation steps and higher sensitivity (as in benzocaine 1-20 lg mL À1 ). The proposed methods were found to be sensitive and selective and do not require complex algorithm, software programs (like matlab) or sophisticated calculation, thus, could be easily applied in QC laboratories lacking liquid chromatographic instruments.
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